Intra-Cellular Therapies Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 44,970 | 0.0424% |
General Public | 2,070,161 | 1.95% |
Individual Insiders | 2,236,624 | 2.11% |
Institutions | 101,665,348 | 95.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,116,229 | €899.7m | -1.03% | 0.06% | |||
9,628,253 | €779.3m | 0.22% | 0.01% | |||
6,219,077 | €503.4m | -1.62% | 0.01% | |||
5,165,365 | €418.1m | 52.1% | 0.05% | |||
4,743,770 | €384.0m | 0% | 100.0% | |||
3,848,588 | €311.5m | 3.51% | 1.09% | |||
3,050,000 | €246.9m | 1.67% | 3.46% | |||
2,965,239 | €240.0m | 5.47% | 0.07% | |||
2,485,627 | €201.2m | 0.58% | 2.48% | |||
1,943,730 | €157.3m | 0% | 0.01% | |||
1,858,915 | €150.5m | 3.14% | 0.01% | |||
1,729,729 | €140.0m | 0.47% | 0.1% | |||
1,708,301 | €138.3m | 1.31% | 0.01% | |||
1,622,215 | €131.3m | -5.49% | 2.96% | |||
1,619,268 | €131.1m | 29% | 0.12% | |||
1,600,693 | €129.6m | 4.08% | 4.06% | |||
1,507,506 | €122.0m | 8.53% | 0.04% | |||
1,439,026 | €116.5m | -8.11% | 4.37% | |||
1,394,196 | €112.8m | 0.02% | 0.93% | |||
1,370,831 | €111.0m | -7.36% | 0.45% | |||
1,208,338 | €97.8m | -11.6% | 0.03% | |||
1,160,973 | €94.0m | 133% | 0.14% | |||
1,159,356 | €93.8m | 11.2% | 0.41% | |||
1,070,329 | €86.6m | 0% | no data | |||
1,042,455 | €84.4m | -27% | 0.01% |